1. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
   Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
2. Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
   Qian Zuo et al, 2024, Chinese Journal of Integrative Medicine CrossRef
3. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway
   Huhu Zhang et al, 2023, Journal of Translational Medicine CrossRef
4. The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents
   Saabira Banu Sahubar Sadik et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
5. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges
   Chaochao Yu et al, 2022, Journal of Zhejiang University-SCIENCE B CrossRef
6. Bufalin for an innovative therapeutic approach against cancer
   Laura Soumoy et al, 2022, Pharmacological Research CrossRef
7. Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells
   Yu Gao et al, 2024, Journal of Liposome Research CrossRef
8. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC
   Rakshmitha Marni et al, 2023, Life Sciences CrossRef
9. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development
   Tianshu Zhang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
10. mPEG-Cholic acid/TPGS mixed micelles for combined delivery of paclitaxel and bufalin to treat hepatocellular carcinoma
    Yujia Liu et al, 2022, Pharmaceutical Development and Technology CrossRef